Status:

WITHDRAWN

The Perinatal Synergistic Multi-component Intervention to alLeviate dEpressive Symptoms. A Case Series

Lead Sponsor:

Washington University School of Medicine

Conditions:

Postpartum Depression

Eligibility:

FEMALE

Phase:

PHASE2

PHASE3

Brief Summary

The goal of this open label case series is to learn about the feasibility of conducting a future randomised controlled trial to evaluate how well the Perinatal SMILES intervention works in improving p...

Detailed Description

The investigators will perform an open-label case series to evaluate the feasibility of performing a trial of a novel intervention to reduce postpartum depression symptoms after cesarean delivery. The...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • English-speaking (necessary for IPT under the limitations of the pilot) Socio-economically disadvantaged (i.e., low-income requiring public assistance) Suffering with depressive symptoms (EPDS \> 10) \>18 years of age \> 20 weeks pregnant scheduled for cesarean delivery" or "within 48 hours of an unscheduled (or scheduled) cesarean delivery.
  • Exclusion Criteria
  • An allergy to ketamine
  • Contraindications for TMS including the presence of metallic objects within 30 cm of the TMS coil, intracranial implants (e.g., aneurysm clips, shunts, stimulators, cochlear implants, or electrodes) or any other metal object within or near the head, excluding the mouth, that cannot be safely removed; presence of intracardiac lines, defibrillators or a cardiac pacemaker and unable to assess safety; presence of implanted electronic devices that control physiologic functions and unable to assess safety
  • Have a personal history of a primary seizure disorder or a seizure associated with an intracranial lesion
  • History of severe head trauma or neurological disorders (e.g., pre-eclampsia) that substantially increase seizure risk, per PI discretion

Exclusion

    Key Trial Info

    Start Date :

    October 15 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 15 2025

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT06048263

    Start Date

    October 15 2025

    End Date

    October 15 2025

    Last Update

    October 29 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Barnes-Jewish Hospital

    St Louis, Missouri, United States, 63110